Zobrazeno 1 - 10
of 156
pro vyhledávání: '"D. Zemer"'
Autor:
D Zemer, O S Better
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 116:548-552
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86e8c665f89eb7aedc1262552b02fd32
https://doi.org/10.1055/s-2008-1063647
https://doi.org/10.1055/s-2008-1063647
Publikováno v:
The Israel Medical Association journal : IMAJ. 1(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bcb82032e5554375efd92f74f327a5d2
https://pubmed.ncbi.nlm.nih.gov/11370119
https://pubmed.ncbi.nlm.nih.gov/11370119
Autor:
N, Gang, J P, Drenth, P, Langevitz, D, Zemer, N, Brezniak, M, Pras, J W, van der Meer, A, Livneh
Publikováno v:
The Journal of rheumatology. 26(4)
To elucidate the role of cytokines in the pathogenesis of familial Mediterranean fever (FMF), an inherited disease characterized by attacks of serosal membrane inflammation.Blood samples were obtained from patients with FMF during attacks and remissi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff51ca26e1cda7b9224789c97434e9d7
https://pubmed.ncbi.nlm.nih.gov/10229412
https://pubmed.ncbi.nlm.nih.gov/10229412
Publikováno v:
Harefuah. 133(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::28ab30dcd6b10ecee5b346d11d7efa7d
https://pubmed.ncbi.nlm.nih.gov/9418342
https://pubmed.ncbi.nlm.nih.gov/9418342
Publikováno v:
European journal of clinical pharmacology. 52(1)
Objective: To investigate a long-term colchicine treatment in inhibiting normal release of insulin, in response to a glucose load. Setting: The Heller Institute of Medical Research, Sheba Medical Center, Tel-Hashomer. Patients: Thirty-one familial Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b71945cf913f531747f17c472c7a3031
https://pubmed.ncbi.nlm.nih.gov/9143863
https://pubmed.ncbi.nlm.nih.gov/9143863
Publikováno v:
QJM : monthly journal of the Association of Physicians. 89(3)
We have previously demonstrated an altered pattern of tumor necrosis factor (TNF) secretion in patients with familial Mediterranean fever (FMF). To examine whether TNF determination could assist in diagnosing FMF, we stimulated heparinized blood of 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd82a4411feccbd0e83ad2bc76f08f12
https://pubmed.ncbi.nlm.nih.gov/8731564
https://pubmed.ncbi.nlm.nih.gov/8731564
Publikováno v:
European journal of clinical pharmacology. 51(3-4)
Colchicine therapy is complicated by frequent gastrointestinal adverse effects.We compared intestinal permeability in 21 patients with familial Mediterranean fever on long-standing colchicine therapy (mean 5.8 years) and significant gastrointestinal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a4cf442848f60994c05962cfe24bdcc
https://pubmed.ncbi.nlm.nih.gov/9010692
https://pubmed.ncbi.nlm.nih.gov/9010692
Publikováno v:
Israel journal of medical sciences. 31(10)
Abdominal pain and diarrhea are frequent side effects of chronic colchicine therapy. Drug-induced lactose deficiency has been demonstrated in the experimental animal. Lactose malabsorption was assessed by the lactose breath test in 23 patients with f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::974aa2269caf09e931da64efcac50087
https://pubmed.ncbi.nlm.nih.gov/7591685
https://pubmed.ncbi.nlm.nih.gov/7591685
Publikováno v:
Acta physiologica Scandinavica. 153(3)
Intestinal permeability was determined in rats receiving colchicine 0.5 +/- 0.15 mg day-1 in drinking water (30 mg L-1) for periods up to 23 days. The lactulose/mannitol method was used to determine whole gut permeability before and on days 2, 4, 8,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e88dd46b7a0977d71d9d79d6012db905
https://pubmed.ncbi.nlm.nih.gov/7625177
https://pubmed.ncbi.nlm.nih.gov/7625177
Publikováno v:
Arthritis and rheumatism. 37(12)
To elucidate factors possibly influencing the outcome of colchicine therapy in patients with amyloidosis of familial Mediterranean fever (FMF).Retrospective analysis of data abstracted from the charts of all 68 FMF patients with amyloidosis who prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c91644ddc9b99b29acf66b122e3e223c
https://pubmed.ncbi.nlm.nih.gov/7986228
https://pubmed.ncbi.nlm.nih.gov/7986228